Search research articles
Contact Us
Filters
Showing results (31-40 of 92) with videos related to
Page
of 10
Sort By:
Journal of Neuro-Oncology
|
December 1, 2016
First use of patient reported outcomes measurement information system (PROMIS) measures in adults with neurofibromatosis
Mojtaba Talaei-Khoei, Eric Riklin, Vanessa L Merker, et al.
Brain Communications
|
April 7, 2023
Vestibular dysfunction in neurofibromatosis type 2-related schwannomatosis
Amsal S Madhani, Susan King, Jennifer Zhu, et al.
Neuro-Oncology
|
October 11, 2017
Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations
John C DeWitt, Justin T Jordan, Matthew P Frosch, et al.
Cancers
|
June 19, 2024
Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related Schwannomatosis
Simeng Lu, Zhenzhen Yin, Jie Chen, et al.
Journal of Neuro-Oncology
|
November 10, 2017
Health literacy assessment in adults with neurofibromatosis: electronic and short-form measurement using FCCHL and Health LiTT
Vanessa L Merker, Sarah McDannold, Eric Riklin, et al.
Neurology
|
June 25, 2025
Principles for Novel Neurologic Therapeutics: An AAN Position Statement
Larry B Goldstein, Jonathan R Crowe, Anindita Deb, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 24, 2022
COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis
Jineta Banerjee, Jan M Friedman, Laura J Klesse, et al.
Orphanet Journal of Rare Diseases
|
February 1, 2021
The impact of the COVID-19 pandemic on neurofibromatosis clinical care and research
Heather B Radtke, Bonita P Klein-Tasman, Vanessa L Merker, et al.
BMC Neurology
|
June 24, 2026
Characteristics, treatment patterns, healthcare resource use, and costs among adult patients diagnosed with neurofibromatosis type 1 and plexiform neurofibromas in the United States
Xiaoqin Yang, Mavis Obeng-Kusi, Theresa Dettling, et al.
Neurology
|
April 30, 2020
Correlation between NF1 genotype and imaging phenotype on whole-body MRI: NF1 radiogenomics
Yunpeng Liu, Justin T Jordan, Miriam A Bredella, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 92) with videos related to
Sort By:
Page
of 10
Journal of Neuro-Oncology
|
December 1, 2016
First use of patient reported outcomes measurement information system (PROMIS) measures in adults with neurofibromatosis
Mojtaba Talaei-Khoei, Eric Riklin, Vanessa L Merker, et al.
Brain Communications
|
April 7, 2023
Vestibular dysfunction in neurofibromatosis type 2-related schwannomatosis
Amsal S Madhani, Susan King, Jennifer Zhu, et al.
Neuro-Oncology
|
October 11, 2017
Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations
John C DeWitt, Justin T Jordan, Matthew P Frosch, et al.
Cancers
|
June 19, 2024
Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related Schwannomatosis
Simeng Lu, Zhenzhen Yin, Jie Chen, et al.
Journal of Neuro-Oncology
|
November 10, 2017
Health literacy assessment in adults with neurofibromatosis: electronic and short-form measurement using FCCHL and Health LiTT
Vanessa L Merker, Sarah McDannold, Eric Riklin, et al.
Neurology
|
June 25, 2025
Principles for Novel Neurologic Therapeutics: An AAN Position Statement
Larry B Goldstein, Jonathan R Crowe, Anindita Deb, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 24, 2022
COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis
Jineta Banerjee, Jan M Friedman, Laura J Klesse, et al.
Orphanet Journal of Rare Diseases
|
February 1, 2021
The impact of the COVID-19 pandemic on neurofibromatosis clinical care and research
Heather B Radtke, Bonita P Klein-Tasman, Vanessa L Merker, et al.
BMC Neurology
|
June 24, 2026
Characteristics, treatment patterns, healthcare resource use, and costs among adult patients diagnosed with neurofibromatosis type 1 and plexiform neurofibromas in the United States
Xiaoqin Yang, Mavis Obeng-Kusi, Theresa Dettling, et al.
Neurology
|
April 30, 2020
Correlation between NF1 genotype and imaging phenotype on whole-body MRI: NF1 radiogenomics
Yunpeng Liu, Justin T Jordan, Miriam A Bredella, et al.
Page
of 10